2017
DOI: 10.1177/0003489417693013
|View full text |Cite
|
Sign up to set email alerts
|

IncobotulinumtoxinA Injection for Temporomandibular Joint Disorder

Abstract: We demonstrate utility of IncobotulinumtoxinA in treating patients with TMD with pain despite pain medication usage and other conventional treatments.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

7
53
0
2

Year Published

2018
2018
2024
2024

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 43 publications
(62 citation statements)
references
References 12 publications
(17 reference statements)
7
53
0
2
Order By: Relevance
“…We found 4 ongoing trials 12,23,33,40 that compared BTX-A versus placebo; these may contribute data in a future update of this review. We included 12 studies 1,7,10,16,17,24,26,35,37,39,51,54 in the review; 9 of these contributed data to meta-analyses (Fig 1).…”
Section: Search Resultsmentioning
confidence: 99%
See 4 more Smart Citations
“…We found 4 ongoing trials 12,23,33,40 that compared BTX-A versus placebo; these may contribute data in a future update of this review. We included 12 studies 1,7,10,16,17,24,26,35,37,39,51,54 in the review; 9 of these contributed data to meta-analyses (Fig 1).…”
Section: Search Resultsmentioning
confidence: 99%
“…Ten 1,7,16,17,24,26,37,39,51,53 of the 12 studies were parallel design RCTs and 2 10,34 were crossover trials. The 12 studies included 362 participants in total, mostly women (87.2%), between 26 and 69 years of age.…”
Section: Characteristics Of Included Studiesmentioning
confidence: 99%
See 3 more Smart Citations